HP
PCPC.WS

Hartree Partners’s Periphas Capital Partnering Corporation Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $28.75 PCPC.WS Stock Holding History

Hartree Partners’s Portfolio PCPC.WS Stock Details PCPC.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$285K Hold
175,000
– – 0.07% 88
2021
Q3 		$266K Hold
175,000
– – 0.07% 88
2021
Q2 		$376K Buy
+175,000
New +$329K 0.09% 86

Other funds holding PCPC.WS

SRCM
Sage Rock Capital Management New York $22.3M AUM 4.09% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Hartree Partners's PCPC.WS Position: Q2 2021 in Review

Hartree Partners sold out of Periphas Capital Partnering Corporation Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $28.75 (PCPC.WS) in Q2 2021, closing a stake of 175,000 shares — an estimated $329K sold.

Hartree Partners first reported a position in PCPC.WS in Q1 2021 and held it in 1 quarter. The position peaked at $378K in Q1 2021. 35 funds tracked by Wall St. Rank hold PCPC.WS as of Q2 2021.

  • Hartree Partners reported no remaining Periphas Capital Partnering Corporation Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $28.75 position as of Q2 2021 after selling out during the quarter.
  • Hartree Partners sold 175,000 Periphas Capital Partnering Corporation Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $28.75 shares in Q2 2021, an estimated $329K.
  • Hartree Partners first reported a position in Periphas Capital Partnering Corporation Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $28.75 in Q1 2021 and held it in 1 quarter.
  • Hartree Partners's Periphas Capital Partnering Corporation Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $28.75 position peaked at $378K in Q1 2021.
  • 35 funds tracked by Wall St. Rank held Periphas Capital Partnering Corporation Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $28.75 as of Q2 2021.

Based on Hartree Partners's 13F filing for Q2 2021, filed 17 Aug 2021.